January 30, 2025 – Prostate Cancer Patient on the Podcast and more news…

Published: January 30, 2025

January 30, 2025

Focused Ultrasound for Lewy Body Dementia: Clinical Trial Explores Cognitive Decline

The UK Focused Ultrasound Foundation and Race Against Dementia will fund a 30-participant trial at the University of Oxford and University College London.
This study marks the first time focused ultrasound neuromodulation will be used in a clinical trial for Lewy body dementia.

Podcast: Prostate Cancer Patient Shares His Focused Ultrasound Story

Robert details his procedure, which allowed him to avoid a hospital stay and go to dinner that night.
Now cancer-free, he is a passionate advocate for focused ultrasound and has spoken to US policymakers about his experience.

Listen to the Episode

Focused Ultrasound Comparable to Radical Prostatectomy for Localized Prostate Cancer

Results from a large multicenter study directly comparing focused ultrasound with radical prostatectomy surgery were recently published.
Two and a half years after treatment, focused ultrasound had similar disease control scores with less incontinence and impotence.

Transforming Cancer Treatment with Gene Editing Using Focused Ultrasound–Driven CRISPR Tools

Researchers demonstrated that focused ultrasound–inducible CRISPR enabled precise, noninvasive genetic editing.
Combining focused ultrasound with CRISPR could enhance CAR-T cell therapy while reducing the risks of off-target effects.

Profound Medical News: Siemens Collaboration and Reimbursement for Prostate Disease

In December, Profound announced a new sales and marketing partnership with Siemens Healthineers.
New insurance payment rates to treatment centers went into effect on January 1 for the TULSA procedure.

Meeting Report: International Symposium on Therapeutic Ultrasound (ISTU) 2024

ISTU 2024 was held September 19–22 in Taipei, Taiwan.
Awards were given by ISTU and the Foundation to recognize important contributions to the field.

Advances in Focused Ultrasound: 2024 Review on Bioeffects and Safety

Focused ultrasound continues to gain traction for applications in immunotherapy and cancer treatment, as well as neuromodulation.
Comprehensive safety protocols and innovative image-guidance methods have been developed to ensure efficacy and minimize risks.

Forwarded this email by a friend? Sign up to receive these emails here.

And Don't Miss

Meeting Report | Taiwan Association of Interventional and Therapeutic Ultrasound (TAITU) 2024

Listen to the Latest ISTU Webinar | Sonobiopsy: Using Focused Ultrasound to Aid in Diagnosis and Disease Monitoring

Get the Latest Focused Ultrasound News in your Inbox | Sign up for our Digest Emails

See Recent News

Events

February 26-March 2, 2025 European Congress of Radiology (ECR), Vienna, Austria

February 27-March 2, 2025 Society for Brain Mapping & Therapeutics (SBMT) 22nd Annual World Congress, Los Angeles, California, USA

March 4-5, 2025 Bioelectronic Med Summit: Neurotechnologies for Individuals and Communities, Garden City, New York, USA

See All Upcoming Events

Do you have news for our newsletter? Tell us about it!

“One in eight men can end up with prostate cancer, and that’s one in four for African American men. Veterans have a high instance as well. So, it's the kind of thing where the awareness just needs to be elevated.”

‒ Robert, a patient, on why he’s passionate about focused ultrasound advocacy

January 30, 2025 – Prostate Cancer Patient on the Podcast and more news…

Contact

Terms of Use